Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Clinical management of the newly diagnosed patient with PAH requires a strong multidisciplinary team. This case-based lecture will cover the most-recent guidelines for initiating PAH therapy in the newly diagnosed as well as team roles in managing patients through the process of dealing with this life-threatening condition.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Acute right ventricular failure can be a devastating complication of severe PAH. Because of the differences between the left and right sides of the heart, tools and techniques dealing with left-heart failure often do not apply in the setting of the right heart or may even be counter-productive. Intensive care management of RV failure in this setting is extremely complex. This lecture provides top-line expert consensus on managing acute RV failure, including bridge-to-transplant options.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

While surgical resection of thromboembolic lesions may be curative, in clinical practice many patients are not appropriate candidates for surgery, especially those with distal lesions. In addition, some patients who have undergone successful surgery may continue to have residual pulmonary hypertension. Data on medical management of inoperable or residual CTEPH has begun to emerge and will be presented.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

New information is constantly being learned about the novel coronavirus, COVID-19. These slides will cover the latest clinical topic updates and perspectives as well as current guidelines, protocols and resources to support people with PAH.

As this is a rapidly evolving situation this website is being updated regularly.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Patients seen in a typical rheumatology practice are at higher risk of PAH secondary to their conditions. Rheumatologists should maintain a high index of suspicion for PAH in their patients with systemic sclerosis and other mixed connective tissue disorders. This lecture will present recommendations for routine screening of patients in a rheumatology practice for PAH as well as the basics of diagnosis and management of PAH.

Activity Summary:
The Simply Speaking PAH lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Research shows that patients with PAH benefit greatly from early diagnosis and treatment. However, patients often face delays of two years or longer from the onset of symptoms before a definitive diagnosis of PAH is reached. Designed for primary care providers and other non-specialists, this case-based, interactive lecture will cover the basics of the diagnosis of PAH, including discussions of the most-common alternative/incorrect diagnoses received by patients.

Activity Summary:
Research shows that there is as much as a 2-year median lag between the time patients present with symptoms associated with PAH and a definitive diagnosis through right-heart catheterization. Millions of patients are seen annually in emergency and urgent care settings, often as their single point of contact with the US healthcare system.

These educational mini modules will outline the hallmarks of various forms of pulmonary hypertension, including PAH, in the hopes of triggering earlier referral for specific screening and diagnostic testing. In addition, recommendations for dealing with the already diagnosed PAH patient who presents for emergent/urgent care will be discussed.

Activity Summary:
The goal of PAH therapy should be not merely to lengthen a patient’s lifespan, but to allow them to fully participate in day-to-day activities. Traditional methods of monitoring patient progress on therapy and/or disease progression often overlook aspects of living that are most important to the patient. In addition, patients often are reluctant to discuss these matters with their clinicians.

These educational mini modules will outline quality-of-life measurements and patient-reported outcomes in PAH, how those measures intersect with traditional clinical outcomes, and how those measurements can be applied to clinical practice.

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge in the field are eagerly anticipated.

These educational Clinical Clips® will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the the American College of Chest Physicians Annual Meeting in San Antonio, Texas, October 6-10 2018, through a series of two ‘what you need to know in 5-minutes’ videos.

Activity Summary:
PAH is a rapidly progressive life-threatening condition in children. Improved awareness among primary care clinicians and others who care for children is essential to raise awareness of the differences in presenting symptoms and diagnostic screening for this rare condition compared with other common complaints.

These educational mini modules will outline screening and diagnosis, general care measures, and PAH-specific therapy, including children with congenital heart disease-related PH.

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in San Diego, California, May 19-23 2018, through a series of two ‘what you need to know in 5-minutes’ videos.

Activity Summary:
The introduction of cystic fibrosis transmembrane regulator (CFTR) modulator therapy represented a true break¬through in overcoming the genetic defects underlying cystic fibrosis (CF). Small-molecule therapy with a single agent, and a combination of that agent with a second complementary agent, has successfully improved meaningful clinical outcomes in patients with specific CF genotypes. This success has led to intensive research and development efforts to expand treatment options to broader populations of CF patients. As new agents become available, clinicians will need to make informed decisions about selecting appropriate therapy for individual CF patients.

These educational Mini Modules will outline the use of current CFTR modulator therapies, expectations for addressing unmet clinical needs with new therapies, and issues around integrating new therapies into clinical practice.

Activity Summary:
PAH patients have a wide variety of both ongoing and acute-care clinical needs. A variety of special clinical situations present themselves in this population.

These educational Mini Modules will outline clinical situations that include issues related to weight management and the development/recognition of sleep apnea in patients with PAH; treatment of atrial fibrillation/atrial flutter; preventing and managing acute respiratory infections; and issues related to the delivery of intravenous prostacyclins.

Activity Summary:
Recently, modulators of the cystic fibrosis transmembrane regulator (CFTR) have been introduced as new therapy options for patients with cystic fibrosis (CF). Initial clinical experience with these agents indicates that their administration can be challenging to manage, being associated with adverse reactions in some patients. Some patients also have difficulty maintaining adherence to dosing regimens required for CFTR modulators and regimens involving co-administration of other chronic CF therapies.

This educational Mini Module will outline practical, clinically applicable approaches for minimizing and managing adverse events associated with CFTR modulators and for optimizing adherence.

Activity Summary:
Even though treatment options for patients with PAH have greatly improved over the last several years, patients need to be closely monitored and therapy altered in order to avoid clinical deterioration.

These educational Mini Modules will outline how to monitor patients on initial PAH treatment to determine when patients need to have their PAH-specific therapy altered. Treatment regimens for the patient who has progressed or is at risk of disease progression will be discussed. The modules will also cover transplant wait-listing and other issues related to end-stage PAH.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Clinical management of the newly diagnosed patient with PAH requires a strong multidisciplinary team.

These educational Mini Modules will outline the most-recent guidelines for initiating PAH therapy in the newly diagnosed as well as team roles in managing patients through the process of dealing with this life-threatening condition.

Updated information is noted on the slide in the upper right-hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
While PH/PAH is a collection of diseases and conditions with diverse etiologies, the majority of clinical trial data has featured a narrow spectrum of illness. Extrapolating clinical trial data from one population to another group has not been proven to demonstrate similar levels of efficacy or safety. Additionally, within the “traditional” PAH population, the subgroup of males with IPAH/APAH have consistently showed a more-rapid course of illness than females.

These educational Mini Modules will outline the issue of the gender paradox, as well as diagnostic and treatment issues relating to PAH related to liver disease (portopulmonary hypertension), PAH related to drugs and toxins, out-of-proportion PAH associated with chronic obstructive pulmonary disease (COPD), and patients with Group 1 PAH, which includes pulmonary vaso-occlusive disease (PVOD) and/or pulmonary capillary hemangiomatosis (PCH).

Activity Summary:
Management of patients with PAH requires a holistic, multidisciplinary effort. Nurses working in the fields of pulmonology, cardiology, rheumatology, and intensive care should have a clear understanding of the diagnostic criteria, quality-of-life issues and medical management considerations for patients diagnosed with pulmonary arterial hypertension.

These educational Mini Modules will outline appropriate diagnostic testing, the risk-benefit equation for specific PAH therapies and associated treatments, and nursing methods of support in crucial clinical management roles to improve patient quality-of-life and medical outcomes.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.